Childhood B-cell Acute Lymphoblastic Leukemia

Top drugs studied for this disease

CLINICAL_TRIALS trial_result · 2025-06-29
Clinical Trial Update: Study of CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults w/ Recurrent or Refractory B Cell Malignancies [Phase 1]
Phase 1 study evaluating CD19/CD22 CAR-T cells in children and young adults with recurrent or refractory B-cell acute lymphoblastic leukemia…